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Abstract: I n t r o d u c t i o n: Hypoplastic left  heart syndrome (HLHS) is a congenital heart anomaly 
that is diagnosed prenatally or postnatally. Th e prenatal diagnosis leads to limiting the rate of systemic 
complications in the preoperative period due to optimization of the early therapeutic management.
O b j e c t i v e: Th e objective of the study is to determine the eff ect of prenatal diagnostic management of 
HLHS on the condition of newborns and the frequency of antibiotherapy employment prior to the fi rst 
stage of surgical treatment.
M e t h o d o l o g y: Th e study included 95 children with HLHS operated on in the years 2014–2016. Th e 
cohort was divided into two groups: newborns with a prenatally diagnosed heart defect (50 children 
— 52.6%) and neonates with the defect diagnosed aft er birth (45 children — 47.4%). Th e data of the 
patients were analyzed based on their medical records.
R e s u l t s: Th e mean age of the children upon admission was 3.86 days in the group of patients with 
the prenatally diagnosed heart defect (PreHLHS) and 7.41 days in the group of newborns without the 
prenatal diagnosis (PostHLHS) (p = 0.001). In 60% of the PreHLHS group patients (30/50), at least one 
antibiotic was administered, while in the PostHLHS group, antibiotherapy was employed in 93.3% (42/45) 
cases (p = 0.001). Bacteriological tests demonstrated pathogen growth in 33 children (36% and 33.3%, 
respectively), what accounted for 34.7% of the entire cohort. On the average, the fi rst antibiotic was 
introduced on the 6.55th day of life in the PreHLHS group and on the 2.73th day in the PostHLHS 
group (p = 0.005). Th e most profound diff erences in antibiotic employment involved aminoglycosides. Th e 
aforementioned type of antibiotic medications was administered to 6% of the children with the prenatal 
diagnosis and to 17.8% of the children diagnosed postnatally (p = 0.042).
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C o n c l u s i o n s: Preoperative antibiotherapy in children with HLHS was employed more frequently 
than it would be indicated by microbiology tests results.
Antibiotics were observed to be introduced more commonly and earlier in the newborns with the 
postnatally diagnosed congenital heart defect.
Key words: prenatal diagnosis, hypoplastic left  heart syndrome, antibiotherapy, Norwood operation.
Introduction
Hypoplastic left  heart syndrome (HLHS) is the most common complex single 
ventricle-type congenital heart defect [1]. Th e syndrome may include hypoplastic or 
absent left  ventricle, mitral valve stenosis or atresia, aortic valve stenosis or atresia 
and ascending aorta and aortic arch hypoplasia [2]. To date, the etiology of the defect 
is unknown.
At present, thanks to the development of diagnostic techniques, the diagnosis of 
HLHS may be established as early as in the fi rst trimester of fetal life [3]. Prenatal 
echocardiography allows for detecting approximately 90% of cases of left heart 
hypoplasia [4]. Diagnosing the defect is an indication for surgical treatment; the 
method of choice is a multi-stage surgical procedure, with the Norwood procedure 
as the initial palliation [5, 6]. Th e clinical picture of HLHS develops over the fi rst 
several days of life in consequence of the ductus arteriosus closure. Th e resultant 
symptoms of cardiogenic shock resemble the symptoms of septic shock and this is 
why the patient is erroneously diagnosed as a victim of an intrauterine infection. Th e 
eff ect is administration of antibiotics. Th e prenatal diagnosis of the defect allows for 
an early intravenous infusion of prostaglandin E1, thus contributing to decreasing 
the morbidity rate acting through the mechanism of increasing cardiovascular 
capacity, improving organ perfusion, renal function and decreasing the incidence 
of neurological complications [7]. Th e prenatal diagnosis does not aff ect survival 
rates aft er the fi rst stage of treatment; early prevention of the neonate developing 
circulatory insuffi  ciency protects the newborn from acidosis and multi-organ failure 
that is manifested by increased concentration levels of lactates, creatinine and alanine 
aminotransferase [8–11]. In case a congenital infection is suspected, broad-spectrum 
chemotherapeutic agents are recommended. Nevertheless, they have nephrotoxic 
(aminoglycosides, cephalosporins), ototoxic and even cardiotoxic (aminoglycosides) 
eff ects [12, 13]. Th e prenatal diagnostic management provides an opportunity to 
protect the general condition of the newborn and to promptly transport the child to 
a cardiac surgery center, but it also may aff ect preventing the development of adverse 
eff ects of the administered antibiotics [14].
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Material and Methods
Th e investigation was carried out based on the retrospective analysis of medical 
records of 95 neonates with HLHS operated on in the years 2014–2016. Depending 
on the time when the defect was diagnosed, the cohort was subdivided into two 
groups: newborns with prenatally diagnosed PreHLHS (n = 50) and newborns 
without prenatally diagnosed PostHLHS (n = 45). Th e statistical analysis included 
demographic data, age and infl ammatory state parameters upon admission to the 
cardiac surgery center, age at the time of the Norwood procedure, identifi ed bacterial 
pathogens, anatomical HLHS variants and 30-day postoperative mortality rates. 
Additionally, the authors analyzed the association between the time and type of the 
employed antibiotherapy and the results of bacteriology.
Th e statistical analysis employed the chi-square test, univariate U Mann-Whitney 
and t-Student tests for independent variables and was carried out using the 
Statistica 10 soft ware (Statsoft ), with the signifi cance level assumed to be p <0.05.
Th e objective of the study was the analysis of the eff ect of the prenatal diagnostic 
management of hypoplastic left  heart syndrome on the preoperative use of antibiotics 
prior to the Norwood procedure.
Results
Th e mean age of the newborns upon admission to the cardiac surgery center was 
3.86 days in the PreHLHS group and 7.41 days in the PostHLHS group (p = 0.001). 
Th e minimal age at the onset of hospitalization in both groups was the day of birth, 
while the maximal age was diff erent for the two groups, amounting to 11 days in the 
PreHLHS group and to 25 days and in the PostHLHS group.
Th e age of the majority of the neonates from the two groups ranged between 
the 1st and 20th day of life. Th e children with prenatally diagnosed heart defects 
were operated on the 15th day of life on the average, while the remaining newborns 
between the 16th–18th day of life (p = 0.489). One-half of the PreHLHS neonates 
were subjected to a cardiac surgical procedure between the 1st and 10th day of life. 
In the group of patients without the prenatal diagnostic management, the procedure 
was most commonly performed between the 11th and 20th day of life; such timing 
was seen in 66.7% of the subjects. Th e chance that it would be possible to perform 
the procedure in the group with the prenatal diagnosis between the 1st and 10th day 
aft er birth was almost twofold higher as compared to the group without the prenatal 
diagnosis (OR = 2.04).
Th e mean preoperative hospitalization time was 10.75 days for all the newborns. Th e 
preoperative hospitalization time of the PreHLHS neonates (11.85) did not signifi cantly 
diff er from the time noted in the PostHLHS group (9.77) (p = 0.193) (Table 1).
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Table 1. Preoperative hospitalization of neonates with HLHS. Th e results are presented in the averaged 








Birth body mass (g) 3217.9 (± 510.9) 3296.1 (± 630.5) 3253.5 (± 566.1) 0.544
Age upon admission to 
cardiosurgical center (days) 3.86 (± 2.56) 7.41 (± 5.77) 5.73 (± 4.85) 0.001
Age upon the Norwood 
procedure (days) 15 (± 9.57) 16.18 (± 6.26) 15.57 (± 8.14) 0.489
Time of preoperative 
hospitalization in 
cardiosurgical center (days)
11.85 (± 8.54) 9.77 (± 5.18) 10.75 (± 6.99) 0.193
Mechanical ventilation was required by seven children from the PreHLHS group 
(14%) and 13 children (29%) from the PostHLHS group.
Of the inflammatory state parameters (C-reactive protein, aspartate amino-
transferase, alanine aminotransferase, creatinine, WBC and blood platelet count) 
assessed upon admission to the ward, the activity of liver enzymes significantly 
diff erentiated between the groups (p = 0.035 and 0.007). Th e mean activity of alanine 
and aspartate aminotransferases approximated the upper normal limit (39.85 IU/l and 
49.54 IU/l, respectively) in the group with the prenatally diagnosed defects. In the 
remaining children, the mean ALT and AST values were 55.14 IU/l and 69.35 IU/l 
(Table 2).
Table 2. Biochemical parameters in preoperative blood tests. Th e results are presented in the averaged 










for newborns p value
C-reactive protein (mg/l) 6.73 (± 4.05) 6.55 (± 3.62) <10 0.838
Aspartate 
aminotransferase (IU/l) 49.54 (± 21.46) 69.35 (± 58.39) <40 0.035
Alanine 
aminotransferase (IU/l) 39.85 (± 20.12) 55.14 (± 29.27) <40 0.007
Creatinine (μmol/l) 68.93 (± 24.68) 83.46 (± 51.18) 28–78 0.097
White blood cells 
(thousands/μl) 13 742.86 (± 4 321.41) 15 211.91 (± 6 647.18) 4.0–10.8 × 103 0.209
Blood platelets 
(thousands/μl) 334.10 (± 135.61) 304.98 (± 173.82) 150–450 0.372
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All the admitted patients had echocardiography performed in order to determine 
the precise anatomy of the defect prior to the fi rst stage of surgical treatment of 
HLHS.
Bacteriological tests were performed in materials originating from blood, urine, 
stool and throat smears (Table 3). Th e results were available within up to 24 hours. 
Pathogen growth was demonstrated in 33 children (PreHLHS — 36%; PostHLHS 
— 33.3%), what accounted for 34.7% of the entire cohort (p = 0.33). In the PreHLHS 
group, the most common pathogen was Staphylococcus epidermidis (50% positive 
results), while in the PostHLHS group — Escherichia coli (86.7%) (Table 4). Both 
in the group of neonates in whom the culture showed pathogen growth and in the 
newborns where no such growth was noted, the fi rst antibiotic agent was introduced 
in the 4th–5th day of life (p = 0.291).
Table 3. Bacteriological results in materials collected from blood, stool, urine and throat smears.
BLOOD CULTURE
With prenatal diagnosis Without prenatal diagnosis
Performed in: 11 children (22%) 7 children (16%)
Positive in: 7 children 3 children
Pathogens detected: 13 (7 species) 3 (3 species)
Staphylococcus epidermidis — 6
Escherichia coli — 2
Staphylococcus haemolyticus — 1
Streptococcus viridians — 1
MRCNS — 1
Acinetobacter spp. — 1
Enterococcus spp. — 1
Staphylococcus epidermidis — 1
Escherichia coli — 1
Streptococcus parasanguinis — 1
STOOL CULTURE
With prenatal diagnosis Without prenatal diagnosis
Performed in: 7 children (14%) 9 children (20%)
Positive in: 6 children 9 children
Pathogens detected: 6 (3 species) 18 (8 species)
Escherichia coli — 2
Klebsiella pneumoniae — 2
Pseudomonas aeruginosa — 1
Escherichia coli — 8
Klebsiella pneumoniae — 2
Pseudomonas aeruginosa — 2
Enterococcus faecalis — 2
Enterococcus faecium — 1
Staphylococcus haemolyticus — 1
Staphylococcus epidermidis — 1
Citrobacter freundii — 1
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URINE CULTURE
With prenatal diagnosis Without prenatal diagnosis
Performed in: 5 children (10%) 4 children (9%)
Positive in: 3 children 3 children
Pathogens detected: 3 (3 species) 4 (3 species)
Enterococcus faecalis — 1
Staphylococcus epidermidis — 1
Streptococcus spp. — 1
Enterococcus faecalis — 1
Escherichia coli — 2
Enterococcus faecium — 1
THROAT SMEAR
With prenatal diagnosis Without prenatal diagnosis
Performed in: 5 children (10%) 4 children (9%)
Positive in: 5 children 3 children
Pathogens detected: 8 (5 species) 9 (6 species)
Streptococcus viridians — 3
Staphylococcus epidermidis — 2
Pseudomonas aeruginosa — 1
Escherichia coli — 1
Klebsiella pneumoniae — 1
Streptococcus viridians — 3
Escherichia coli — 2
Pseudomonas aeruginosa — 1
Staphylococcus epidermidis — 1
Klebsiella pneumoniae — 1
Haemophilus infl uenza — 1
Table 4. Pathogens detected in microbiological tests*, including single methicillin-resistant 









Gram-negative bacteria 14 25 39
Escherichia Coli 5 13 18
Klebsiella pneumoniae 4 3 7
Enterococcus spp. 2 4 6
Pseudomonas aeruginosa 2 3 5
Haemophilus spp. 0 1 1
Acinetobacter spp. 1 0 1
Citrobacter spp. 0 1 1
Gram-positive bacteria 16 8 24
Staphylococcus epidermidis 9 3 12
Staphylococcus haemolyticus 1 1 2
Streptococcus spp. 6* 4 10
Table 3. Cont.
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In the PreHLHS group, antibiotherapy was employed in 60%, while in the 
PostHLHS group — in 93.3% of the children (p = 0.001). Th e fi rst antibiotic was 
administered at the mean age of 6.55 days of life in the PreHLHS group and on the 
2.73th day in the PostHLHS group (p = 0.005).
In the PreHLHS patients, several antibiotics were more commonly employed, 
while in the PostHLHS group, mono-antibiotherapy predominated (especially 
penicillin derived antibiotics). The most pronounced intergroup differences in 
antibiotic usage were observed in the case of aminoglycosides (p = 0.042) (Table 5). 
Antibiotics employed in the course of surgery to prevent infections were excluded 
from the analysis.
Table 5. Antibiotics employed preoperatively depending on bacteriology culture results. Statistical 















Penicillins 0 8 6 11 0.065
Cephalosporins 6 5 9 2 0.760
Aminoglycosides 0 3 3 5 0.042
Glycopeptide antibiotics 2 6 1 4 0.391
Carbapenems 1 3 4 3 0.198
Others 0 2 5 1 0.128
Total 9 27 28 26
In both groups of newborns in whom antibiotherapy was employed in spite of 
negative bacteriological results, cephalosporins were statistically more commonly used 
as compared to the remaining kinds of antibiotics (p = 0.022). On the other hand, in 
the newborns whose bacteriology results were positive, penicillin derived antibiotics 
were statistically more commonly administered (p = 0.002), as well as glycopeptide 
antibiotics (p = 0.040).
The mean time of hospitalization in the Cardiosurgical Intensive Care Unit 
following the Norwood procedure was 40.6 days in the PreHLHS group and 48.58 
days in the PostHLHS group.
Discussion
Development of diagnostic methods has resulted in the fact that serious heart defects, 
such as HLHS, may be detected as early as during the fi rst cardiological examination 
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of the fetus that is performed between the 14th and 15th weeks of gestation [15]. 
In the years 2008–2012 in Europe, the percentage of HLHS cases detected prenatally 
was 73.8% [16]. In Poland, the data are similar [17]. Detection of a congenital heart 
defect in the intrauterine period is associated with signifi cant clinical consequences. 
A neonate with prenatally diagnosed hypoplastic left  heart syndrome may reach 
a cardiac surgery center in the 1st or 2nd day of life in good general condition. Th is 
allows for standardization and optimization of perioperative management. Th e time 
in which the prenatally diagnosed newborns were transported to the authors’ center 
was almost twofold shorter as compared to the children who were diagnosed aft er 
birth (4 days vs. 7 days).
A neonate with HLHS that is not subjected to treatment in the first days of 
life begins developing cardiogenic shock. In the face of symptoms suggestive of an 
infection, broad-spectrum antibiotic therapy is empirically introduced, yet, it does 
not result in any improvement [18]. Such a management mode should be regarded 
justified in view of the highly common occurrence of congenital infections in 
neonates. In the present study, the authors demonstrated a signifi cant diff erence in 
antibiotics employment between the two groups. Antibiotic use predominated among 
the children who were diagnosed aft er birth (60% vs. 93%). Th e tendency was even 
more apparent when the time of the fi rst antibiotic introduction was analyzed. In the 
group of the neonates with a prenatally diagnosed heart defect, the fi rst antibiotic 
was administered on the average on the 6th day aft er admission, while the remaining 
children received the medication on the 2nd day of hospitalization. Th e percentage of 
the children who were administered chemotherapeutics was more than twofold higher 
than the percentage of the neonates in whom bacteriology demonstrated pathogen 
growth. Th e analysis of the two groups demonstrated that the ratio was 1.67 in the 
neonates diagnosed prenatally and 2.8 in the group with the postnatal diagnosis. It 
does not necessarily mean that in some cases, the medications were groundlessly 
administered, since the sensitivity of a bacterial culture ranges between 50% and 80%, 
depending on the collected material.
As it follows from the study, the diff erences in antibiotic administration were 
mainly seen in case of aminoglycosides. Th eir use was almost threefold lower among 
the children diagnosed before birth. All aminoglycosides exert a stronger or weaker 
ototoxic and nephrotoxic eff ect [19]. Inasmuch as renal dysfunctions are regarded to 
be reversible [20], hearing impairment is a permanent complication of aminoglycoside 
therapy [21]. Audiometry demonstrated that the problem of ototoxicity may involve 
as many as 62.3% of all patients treated with the aforementioned medications [22]. 
Factors that increase the risk of toxicity include among others age — newborns, low 
initial creatinine clearance, lung and liver diseases. Neonates with diagnosed heart 
defects were observed to be administered antibiotics more frequently and earlier.
 Th e eff ect of prenatal diagnosis on antibiotic therapy in neonates… 43
Acknowledgments, funding, and disclosures
Confl ict of interest — none declared.
No funding.
References
 1. Tchervenkov C.I., Jacobs M.L., Tahta S.A.: Congenital Heart Surgery Nomenclature and Database 
Project hypoplastic left  heart syndrome. Ann Th orac Surg. 2000; 69 (4 Suppl.): S170–S179.
 2. Webb G.D., Smallhorn J.F., Th errien J., Redington A.N.: Congenital heart disease. In: Bonow R.O., 
Mann D.L., Zipes D.P., Libby P., eds. Braunwald’s Heart Disease: A Textbook of Cardiovascular 
Medicine. 9th ed. Philadelphia, PA: Saunders Elsevier; 2011: chap. 65.
 3. Galindo A., Nieto O., Villagrá S., Grañeras A., Herraiz I., Mendoza A.: Hypoplastic left heart 
syndrome diagnosed in fetal life: associated findings, pregnancy outcome and results of palliative 
surgery. Ultra-sound Obstet Gynecol. 2009; 33: 560–566.
 4. Chaoui R.: Fetal echocardiography: state of the art of the state of the heart. Ultrasound Obstet 
Gynecol. 2001; 17 (4): 277–284.
 5. Mroczek T., Sacharczuk J., Żurek R., Morka A., Szypulski A., Jarosz J., Śniechowski M., Skalski J.: 
Th e “double dunk” technique for a right ventricle to pulmonary artery conduit for the Norwood 
procedure reduces the unintended shunt-related events. Kardiol Pol. 2018; 76: 1697–1704.
 6. Szypulski A., Rai V., Sacharczuk J., Gładki M., Morka A., Żurek R., Skalski J.H., Mroczek T.: Risk 
factors for recoarctation of aorta aft er Norwood procedure in patients with hypoplastic left  heart 
syndrome. Folia Med Crac. 2018; 58: 11–21.
 7. Mahle W.T., Clancy R.R., McGaurn S.P., Goin J.E., Clark B.J.: Impact of prenatal diagnosis on survival 
and early neurologic morbidity in neonates with the hypoplastic left  heart syndrome. Pediatrics. 
2001; 107: 1277–1282.
 8. Shaine A., Mary K., Daniel J., Mark A., Charles G., David E., Wendy N.: Prenatal Diagnosis, Birth 
Location, Surgical Center, and Neonatal Mortality in Infants With Hypoplastic Left  Heart Syndrome, 
Circulation. 2014; 129: 285–292.
 9. Tworetzky W., McElhinney D.B., Reddy V.M., Brook M.M., Hanley F.L., Silverman N.H.: Improved 
surgical outcome aft er fetal diagnosis of hypoplastic left  heart syndrome. Circulation. 2001; 103: 
1269–1273.
10. Kipps A.K., Feuille C., Azakie A., Hoff man J.I., Tabbutt S., Brook M.M., et al.: Prenatal diagnosis of 
hypoplastic left  heart syndrome in current era. Am J Cardiol. 2011; 108: 421–427.
11. Satomi G., Yasukochi S., Shimizu T., Takigiku K., Ishii T.: Has fetal echocardiography improved the 
prognosis of congenital heart disease? Comparison of patients with hypoplastic left  heart syndrome 
with and without prenatal diagnosis. Pediatr Int. 1999; 41: 728–732.
12. Cojocel C., Göttsche U., Tölle K.L., Baumann K.: Nephrotoxic potential of fi rst-, second-, and third-
generation cephalosporins. Arch Toxicol. 1988; 62 (6): 458–464.
13. Selimoglu E.: Aminoglycoside-induced ototoxicity. Curr Pharm Des. 2007; 13 (1): 119–126.
14. Allan L.D., Apfel H.D., Printz B.F.: Outcome aft er prenatal diagnosis of the hypoplastic left  hart 
syndrome. Heart. 1998; 79: 371–373. doi: 10.1136/hrt.79.4.371.
15. Vogel M., Sharland G.K., McElhinney D.B., Zidere V., Simpson J.M., Miller O.I., Allan L.D.: Cardiol 
Young. Prevalence of increased nuchal translucency in fetuses with congenital cardiac disease and 
a normal karyotype. 2009; 19 (5): 441–445.
16. EUROCAT Website Database: http://www.eurocat-network.eu.
44 Magdalena Czerżyńska, Mateusz Mleczko, et al.
17. Knafel A., Wiecheć M., Nocuń A., Basta A.: Transposition of great arteries (d-TGA) in the fi rst 
trimester- a case report. Prenat Cardio. 2013; 3 (10): 22–27. doi: 10.12847/09134.
18. Chang R.R., Chen A.Y., Klitzner T.S.: Clinical management of infants with hypoplastic left  heart 
syndrome in the United States, 1988–1997. Pediatrics. 2002; 110: 292–298.
19. English W.P., Williams M.D.: Should aminoglycoside antibiotics be abandoned? Am J Surg. 2000; 
180: 512–515.
20. Edson R.S., Terrell C.L.: Th e aminoglycosides. Mayo Clin Proc. 1999; 74: 519–528.
21. Chiodo A.A., Alberti P.W.: Experimental, clinical and preventive aspects of ototoxicity. Eur Arch 
Otorhinolaryngol. 1994; 251: 375–392.
22. Tange R.A.: Ototoxicity. Adverse Drug React Toxicol Rev. 1998; 17: 75–89.
